SOURCE: Mu Sigma

Mu Sigma

May 02, 2013 09:48 ET

Mu Sigma Presents at Pharmaceutical Management Science Association 2013

Presentation Explores How Pharmaceutical Companies Can Envision the Evolution of Their Payer Mix Over the Coming Years and Strategize Accordingly

CHICAGO, IL--(Marketwired - May 2, 2013) -  Mu Sigma (, the largest pure-play provider of decision sciences and analytics solutions for global enterprise customers, announced today that it will present at Pharmaceutical Management Science Association (PMSA) 2013, taking place May 5-8, 2013 in Bonita Springs, FL. Mu Sigma's presentation "Shift in Payor Mix: How to Predict and What Does it Mean for Pharmaceutical Companies?" will explore the timely topic facing pharmaceutical companies that are looking for ways to better understand their exposure to various payer types as it has a direct impact on their future profitability.

"The managed markets landscape in the United States is changing rapidly. Pharmaceutical companies have seen commercial payer coverage decline for several drugs and other therapeutic areas. Enrollment in Medicaid is expected to increase given the recent Supreme Court ruling on 'Patient Protection and Affordable Care Act.' Changing demographics of the US population, such as aging baby boomers, is also expected to contribute to a shift in payer mix," said Mukund Raghunath, Geography Head, Mu Sigma. "However, most pharmaceutical companies have little visibility into their future business from various payer types. Mu Sigma is working closely with many pharmaceutical companies to tackle this specific issue and introduce analytics to their business which is having a major impact on decisions related to product development and overall bottom line."

In this poster discussion, Mu Sigma will explain how pharmaceutical companies can predict the evolution of their payer mix over the next five years. Mu Sigma will share an approach that incorporates several driving factors including epidemiology, patient/population demographics, healthcare reforms, organic growth and competition to predict future payer mix and profitability and shared strategies that pharmaceutical companies can adopt to maintain profitability in light of the projected payer mix.

Who: Mukund Raghunath, Geography Head, Mu Sigma
What: "Shift in Payor Mix: How to Predict and What Does it Mean for Pharmaceutical Companies?"
Where: Hyatt Regency Coconut Point in Bonita Springs, Florida
When: May 5 - 8, 2013
How: For more information on the events or to register, visit

The Pharmaceutical Management Science Association (PMSA) is a not-for-profit organization whose mission is to efficiently meet society's pharmaceutical needs through the use of management science.

About Mu Sigma
Mu Sigma, one of the world's largest pure-play decision sciences and analytics firms, helps companies institutionalize data-driven decision making and harness Big Data. Mu Sigma solves high-impact business problems in the areas of Marketing, Risk and Supply Chain across 10 industry verticals. With over 2500 decision science professionals and more than 75 Fortune 500 clients, Mu Sigma has driven disruptive innovation in the analytics industry with its interdisciplinary approach combining business, math and technology, and its integrated decision support ecosystem comprised of technology platforms, processes, methodologies and people. Visit

Mu Sigma is a trademark of Mu Sigma, Inc. in the United States and other countries. All other trademarks contained herein are the property of their respective owners.

Contact Information

  • For information, contact:
    Gina Rezendes
    Big Swing Communications
    Email Contact